PACE-C

About this trial

SBRT uses special equipment to accurately deliver a high dose of radiotherapy to the prostate in a smaller number of treatments. This study is being conducted to find out, for patients with localised intermediate/high risk prostate cancer, whether radiotherapy is best given over 4 weeks (standard image-guided intensity modulated radiotherapy IMRT) or over 1-2 weeks using SBRT.

Patient Profile

For patients with localised intermediate/high risk prostate cancer

Where’s this trial being run?

Beacon Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: PACE-C
Number: CTRIAL-IE 15-46
Full Title:

The PACE Trial (Prostate Advances in Comparative Evidence) International randomised study of prostatectomy vs stereotactic body radiotherapy (SBRT) and conventional radiotherapy vs SBRT for organ-confined prostate cancer.
PACE C: Image-Guided Conventional Radiotherapy vs Stereotactic Radiotherapy

Principal Investigator: Prof. John Armstrong / Dr Alina Mihai
Type: Collaborative
Sponsor:

Cancer Trials Ireland
Royal Marsden NHS Foundation Trust

Recruitment Started: Global:
Ireland: February 2021
Global Recruitment Target: 1182
Ireland Recruitment Target: